---
title: "减肥大战：诺和诺德公司的主导地位能否抵挡住礼来的挑战？"
description: "减肥战争：诺和诺德的主导地位能否抵御礼来的挑战？"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/259383895.md"
published_at: "2025-09-29T16:36:03.000Z"
---

# 减肥大战：诺和诺德公司的主导地位能否抵挡住礼来的挑战？

> 减肥战争：诺和诺德的主导地位能否抵御礼来的挑战？

减肥战争：诺和诺德的主导地位能否抵御礼来的挑战？

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)
- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/zh-CN/news/275652909.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/zh-CN/news/275789396.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/zh-CN/news/275761183.md) |
| Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/zh-CN/news/275654518.md) |
| Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/zh-CN/news/275719942.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。